PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
134.01%
Net income growth above 1.5x MRVL's 69.03%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-12.00%
Both reduce yoy D&A, with MRVL at -75.47%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-112.38%
Negative yoy deferred tax while MRVL stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
-262.81%
Both reduce yoy usage, with MRVL at -46.02%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
-378.79%
Negative yoy inventory while MRVL is 7.54%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
No Data
No Data available this quarter, please select a different quarter.
-122.29%
Both reduce yoy usage, with MRVL at -49.20%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-88.30%
Negative yoy while MRVL is 100.00%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-73.66%
Both yoy CFO lines are negative, with MRVL at -68.56%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
44.07%
Some CapEx rise while MRVL is negative at -9.76%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
-39.68%
Negative yoy purchasing while MRVL stands at 74.55%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
318.88%
Proceeds from sales/maturities above 1.5x MRVL's 42.56%. David Dodd would confirm if the firm is capitalizing on strong valuations or freeing liquidity for expansions.
No Data
No Data available this quarter, please select a different quarter.
100.42%
Investing outflow well above MRVL's 77.38%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
-69.23%
Both yoy lines negative, with MRVL at -56.84%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
33.33%
Similar buyback growth to MRVL's 33.33%. Walter Schloss sees parallel capital return priorities or a stable free cash flow for both.